This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Cramer's Action Alerts PLUS - See his portfolio and get alerts BEFORE every trade. Learn more NOW!

Safe In Common To Engage 100,000 Healthcare Personnel Behind Campaign To Protect Millions Now At Risk Of Harm From Needlestick Injuries

Mr. Alan Shortall, CEO of Unilife stated: "Unilife looks forward to working with Safe in Common and other healthcare and pharmaceutical industry leaders who are equally committed to enhancing and saving the lives of healthcare personnel who remain at significant risk of harm from needlestick injuries. A new generation of safety-engineered medical equipment has been developed and launched during the last decade. Products with passive and fully integrated safety features in particular can minimize the risk of needlestick injury to a healthcare worker. It is time to make healthcare personnel more aware of these safer, simpler products."

Cities now scheduled to be visited by Safe in Common during the Needlestick Safety Advocacy Tour are listed below.  Additional cities may be added throughout the year.

  • York, Pa.
  • Harrisburg, Pa.
  • Hersey, Pa.
  • Boston, Mass.
  • New York, N.Y.
  • Orlando, Fla.
  • Washington, DC
  • Phoenix, Ariz.
  • San Antonio, Texas
  • Philadelphia, Pa.
  • New Brunswick, N.J.
  • Hackensack, N.J.
  • Paramus, N.J.
  • Providence, R.I.
  • Hartford, Conn.
  • New Haven. Conn.
  • Chicago, Ill.
  • San Diego, Calif.
  • Los Angeles, Calif.
  • San Francisco, Calif.
  • Houston, Texas
  • Las Vegas, Nev.

About Safe in Common

Safe in Common is a non-profit organization established to enhance and save the lives of U.S. healthcare personnel at risk of harm from needlestick injuries.  It is led by Chairperson Mary Foley, PhD, RN, former President of the American Nursing Association and a U.S. leader for needlestick prevention, Healthcare Safety Advocate Nancy Purcell-Holmes, RN, and other industry leaders. Follow Safe in Common at http://www.facebook.com/safeincommon or http://www.twitter.com/safeincommon.

Safe in Common is proudly supported by its lead sponsor Unilife, a U.S. based global leader for advanced drug delivery systems.

2 of 3

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Try it NOW
Only $9.95
Try it NOW
14-Days Free
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG

Markets

DOW 17,674.09 -102.03 -0.57%
S&P 500 2,054.64 -13.25 -0.64%
NASDAQ 4,860.6690 -40.2160 -0.82%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs